Business Context and Reporting Period
This Form 6-K filing by UBS Group AG and UBS AG, dated November 3, 2015, discloses the consolidated BIS Basel III leverage ratio information as of September 30, 2015. The disclosure is mandated by the revised FINMA Circular 2008/22 and Swiss regulatory requirements effective January 1, 2015.
Key Financial Metrics
The filing focuses exclusively on regulatory capital and leverage metrics rather than operational financial performance (revenue, profit, or cash flow).
- BIS Basel III Leverage Ratio (Fully Applied): 3.9%
- BIS Basel III Leverage Ratio (Phase-in): 4.7%
- Tier 1 Capital (Fully Applied): CHF 36,526 million
- Tier 1 Capital (Phase-in): CHF 44,125 million
- Leverage Ratio Denominator (Fully Applied): CHF 935,536 million
- Leverage Ratio Denominator (Phase-in): CHF 941,216 million
- IFRS Total Assets: CHF 979,746 million
Material Changes and Comparisons
The filing text does not provide comparative data for the prior quarter or year-over-year changes. It references the third quarter 2015 report for information regarding leverage ratio movements but does not include those specific figures in this document.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard regulatory disclosure requirements. It notes that the leverage ratio calculation involves adjustments for derivatives, securities financing transactions, and counterparty credit risk. Investors are directed to the third quarter 2015 report and the Annual Report 2014 for broader context on Swiss SRB leverage ratios and regulatory scope of consolidation.
Investor Verification Checklist
- Verify the full third quarter 2015 report for revenue, profit, and cash flow data not included in this filing.
- Review the "UBS Group AG consolidated supplemental disclosures required under Basel III Pillar 3 regulations" for details on the regulatory scope of consolidation.
- Confirm the distinction between the "fully applied" and "phase-in" leverage ratio bases to understand capital adequacy under different regulatory timelines.
- Check the reconciliation of IFRS total assets to BIS Basel III exposures to understand the impact of derivative and securities financing transaction adjustments.